A REVIEW ON NOVEL NANOEMULGEL FOR OCULAR DRUG DELIVERY
DOI:
https://doi.org/10.53555/eijmhs.v10i1.223Keywords:
Nanoemulgel, ocular drug delivery, nanotechnology, gel-based systems, therapeutic efficacyAbstract
Nanotechnology has been widely used the recent clinical trends, it enhances the potential of the delivery of the drug in ocular target site by reducing complete and partial side effects. Eye is a sophisticated and sensitive structure of the human body their physiology impart a significant role in the delivery of the drug and effectiveness of the drug at target site. Developing efforts in drug delivery has led to progresses of nanoparticle preparation for ocular drugs, Nanoemulgel, is a novel drug delivery system, and has garnered substantial consideration in current years due to its probable to revolutionize ocular drug delivery. Emulsion based nanotechnology or nanoemulgel is a design connected interference to recover the complete distribution and beneficial profile of fat-soluble drugs. Nanoemulgel is a multifaceted preparation of two dissimilar arrangements in which nano emulsion containing drug is fused into a gel base. The combination of these binary systems makes this invention valuable in numerous ways. Lipid based preparations can be easily unified and the permeation through epidermis of the integrated drugs can be boosted in numerous way due to the exceptionally dispersed nanoparticle of nano emulsion. Prior studies demonstrate that this preparation suggestively amended the adsorbtion, distribution, metabolism, excretion and pharmacodynamic parameters of the lipotropic drugs whereas; the character statics of nanoemulgel in ocular drug delivery is limited. The main focus of this study is to assess and describe the current potential and encounters face by the drug delivery system of the loaded drug in Nanoemulgel, and upcoming possibility of nanoemulgel invention for fetching an operative delivery system for hydrophilic drugs. In this assessment, we have briefly discussed the consequence of various studies on absorption, distribution, metabolism, excretion, binding of the drug to their receptor and affinity of the drugs distributed in ocular concluded via nanoemulgel. Reasonableness of use laterally with the foremost tasks to overawed for nanoemulgel invention has been deliberated.
References
Algahtani, M. S., Ahmad, M. Z., Shaikh, I. A., Abdel-Wahab, B. A., Nourein, I. H., & Ahmad, J. (2021). Thymoquinone Loaded Topical Nanoemulgel for Wound Healing: Formulation Design and In-Vivo Evaluation. Molecules , 26, 3863.
Alhasso, B., Ghori, M. U., & Conway, B. R. (2023). Development of a Nanoemulgel for the Topical Application of Mupirocin. Pharmaceutics , 15, 2387.
Almostafa, M. M., Elsewedy, H. S., Shehata, T. M., & Soliman, W. E. (2022). Novel Formulation of Fusidic Acid Incorporated into a Myrrh-Oil-Based Nanoemulgel for the Enhancement of Skin Bacterial Infection Treatment. Gels , 8, 245.
Bashir, M., Ahmad, J., Asif, M., Khan, S.-U.-D., Irfan, M., Y Ibrahim, A., et al. (2021). Nanoemulgel, an Innovative Carrier for Diflunisal Topical Delivery with Profound Anti-Inflammatory Effect: in vitro and in vivo Evaluation. International Journal of Nanomedicine , Volume 16, 1457–1472.
Bhardwaj, S., Gaur, P. K., & Tiwari, A. (2022). Development of Topical Nanoemulgel Using Combined Therapy for Treating Psoriasis. ASSAY and Drug Development Technologies , 20, 42–54.
Cassano, R., Di Gioia, M. L., & Trombino, S. (2021). Gel-Based Materials for Ophthalmic Drug Delivery. Gels , 7, 130.
Donthi, M. R., Munnangi, S. R., Krishna, K. V., Saha, R. N., Singhvi, G., & Dubey, S. K. (2023). Nanoemulgel: A Novel Nano Carrier as a Tool for Topical Drug Delivery. Pharmaceutics , 15, 164.
Kataria, S., Roy, S., Chaurasia, M., Awasthi, H., Fatima, Z., Prasad, R., et al. (2023). Crisaborole loaded nanoemulgel for the mitigation of atopic dermatitis in mice model. Drug Development and Industrial Pharmacy , 49, 521–535.
Konstas, A. G., Schmetterer, L., Katsanos, A., Hutnik, C. M., Holló, G., Quaranta, L., et al. (2020). Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future. Advances in Therapy , 38, 24–51.
Mehanna, M. M., Mneimneh, A. T., & Jalil, K. A. (2020). Levofloxacin-loaded naturally occurring monoterpene-based nanoemulgel: a feasible efficient system to circumvent MRSA ocular infections. Drug Development and Industrial Pharmacy , 46, 1787–1799.
Moosa, R. M., Choonara, Y. E., du Toit, L. C., Tomar, L. K., Tyagi, C., Kumar, P., et al. (2014). In vivo evaluation and in-depth pharmaceutical characterization of a rapidly dissolving solid ocular matrix for the topical delivery of timolol maleate in the rabbit eye model. International Journal of Pharmaceutics , 466, 296–306.
Morsy, Abdel-Latif, Nair, Venugopala, Ahmed, Elsewedy, et al. (2019). Preparation and Evaluation of Atorvastatin-Loaded Nanoemulgel on Wound-Healing Efficacy. Pharmaceutics , 11, 609.
Morteza-Semnani, K., Saeedi, M., Akbari, J., Eghbali, M., Babaei, A., Hashemi, S. M., et al. (2021). Development of a novel nanoemulgel formulation containing cumin essential oil as skin permeation enhancer. Drug Delivery and Translational Research , 12, 1455–1465.
Nagaraja, S., Basavarajappa, G. M., Attimarad, M., & Pund, S. (2021). Topical Nanoemulgel for the Treatment of Skin Cancer: Proof-of-Technology. Pharmaceutics , 13, 902.
Ni, X., Guo, Q., Zou, Y., Xuan, Y., Mohammad, I. S., Ding, Q., et al. (2020). Preparation and characterization of bear bile-loaded pH sensitive in-situ gel eye drops for ocular drug delivery. Iranian Journal of Basic Medical Sciences , 23.
Qamar, Z., Qizilbash, F. F., Iqubal, M. K., Ali, A., Narang, J. K., Ali, J., et al. (2020). Nano-Based Drug Delivery System: Recent Strategies for the Treatment of Ocular Disease and Future Perspective. Recent Patents on Drug Delivery & Formulation , 13, 246–254.
Razzaq, F. A., Asif, M., Asghar, S., Iqbal, M. S., Khan, I. U., Khan, S.-U.-D., et al. (2021). Glimepiride-Loaded Nanoemulgel; Development, In Vitro Characterization, Ex Vivo Permeation and In Vivo Antidiabetic Evaluation. Cells , 10, 2404.
Rizg, W. Y., Hosny, K. M., Mahmoud, S. S., Kammoun, A. K., Alamoudi, A. J., Tayeb, H. H., et al. (2022). Repurposing Lovastatin Cytotoxicity against the Tongue Carcinoma HSC3 Cell Line Using a Eucalyptus Oil-Based Nanoemulgel Carrier. Gels , 8, 176.
Saab, M., Raafat, K., & El-Maradny, H. (2021, October). Transdermal Delivery of Capsaicin Nanoemulgel: Optimization, Skin Permeation and in Vivo Activity Against Diabetic Neuropathy. Advanced Pharmaceutical Bulletin .
Sengupta, P., & Chatterjee, B. (2017). Potential and future scope of nanoemulgel formulation for topical delivery of lipophilic drugs. International Journal of Pharmaceutics , 526, 353–365.
Siddiqui, A., Jain, P., Alex, T. S., Ali, M. A., Hassan, N., Haneef, J., et al. (2022). Investigation of a Minocycline-Loaded Nanoemulgel for the Treatment of Acne Rosacea. Pharmaceutics , 14, 2322.
Taha, M., Alhakamy, N. A., Md, S., Ahmad, M. Z., Rizwanullah, M., Fatima, S., et al. (2022). Nanogels as Potential Delivery Vehicles in Improving the Therapeutic Efficacy of Phytopharmaceuticals. Polymers , 14, 4141.
Tan, A. Y., LeVatte, T. L., Archibald, M. L., Tremblay, F., Kelly, M. E., & Chauhan, B. C. (2002). Timolol Concentrations in Rat Ocular Tissues and Plasma After Topical and Intraperitoneal Dosing. Journal of Glaucoma , 11, 134–142.
Thrimawithana, T. R., Young, S., Bunt, C. R., Green, C., & Alany, R. G. (2011). Drug delivery to the posterior segment of the eye. Drug Discovery Today , 16, 270–277.
Vartak, R., Menon, S., Patki, M., Billack, B., & Patel, K. (2020). Ebselen nanoemulgel for the treatment of topical fungal infection. European Journal of Pharmaceutical Sciences , 148, 105323.
Wei, D., Pu, N., Li, S.-Y., Wang, Y.-G., & Tao, Y. (2023). Application of iontophoresis in ophthalmic practice: an innovative strategy to deliver drugs into the eye. Drug Delivery , 30.
Yeo, E., Yew Chieng, C. J., Choudhury, H., Pandey, M., & Gorain, B. (2021). Tocotrienols-rich naringenin nanoemulgel for the management of diabetic wound: Fabrication, characterization and comparative in vitro evaluations. Current Research in Pharmacology and Drug Discovery , 2, 100019.
